For years, cannabis was framed as a race for footprint. Operators expanded into new states, built facilities, and pursued scale with the expectation that growth alone would attract capital. That approach no longer works.
Cannabis remains a large and economically significant industry. MJBiz Factbook reported $35 billion in U.S. cannabis sales in 2025, with a broader economic impact exceeding $123 billion, yet growth has been slower than the industry anticipated.
Price compression, an entrenched illicit market, and years of stalled federal reform weighed on operator performance and dampened long-term forecasts. That backdrop is beginning to shift.
RELATED: Why Schedule III won’t solve one of cannabis’ biggest problems
The Justice Department’s rescheduling of state-legal medical cannabis to Schedule III took effect in April 2026, reducing the tax burden on licensed medical operators. A federal hearing on adult-use rescheduling is underway, and proposed restrictions on hemp-derived intoxicants stand to redirect a meaningful share of consumer demand back to regulated operators. The policy environment is not resolved, but the direction is changing.
Capital is still available, but those policy tailwinds have not yet translated into looser capital markets. Providers continue to take a conservative underwriting approach focused on durability. That underwriting happens across the state, the operator, and the individual asset. Each layer tells a different part of the story, and all three must hold up under pressure.
In today’s market, cash flow is credibility. Before anything else, capital providers want to know whether an operator is generating real cash and whether that cash can support its obligations. That analysis begins at the operating company level and extends to the asset level.
A key question is whether a specific facility or dispensary can generate enough cash flow on a standalone basis to cover rent or debt service. This distinction is critical because a strong parent company does not guarantee the performance of every asset. In practice, underperforming facilities are often the first to be shut down, regardless of broader corporate strength.
RELATED: Too many dispensaries are missing one important thing
Balance sheet discipline also matters. Operators carrying high leverage at elevated interest rates face increasing scrutiny. In many cases, lenders have already extended or refinanced debt at rates in the mid-teens. If cash flow cannot support those obligations, access to new capital becomes limited.
The question isn’t how fast a company can grow, but rather whether it can sustain itself under current conditions without relying on repeated refinancing.
Scale still matters, but its value depends on how it translates into performance. A broad national footprint is not always an advantage. In many cases, operators with a leading position in a single state are more attractive than those spread across multiple markets. What matters is not how many markets an operator enters, but how well it performs within them.
State structure plays a central role. Limited-license markets tend to offer stronger margins and more stable competitive dynamics. In more competitive and fragmented markets, pricing pressure can be significant, and only operators with sufficient scale, vertical integration or brand strength tend to maintain profitability.
Michigan illustrates this dynamic. The state generated roughly $3.18 billion in adult-use sales in 2025, yet average flower prices fell from $69.20 per ounce in late 2024 to $58.22 a year later. Volume alone does not protect margins. Even newer markets follow a similar pattern. Ohio surpassed $1 billion in cannabis sales in its first full year of adult use, but prices began to decline early in the cycle.
In this environment, operators need a clear plan for how they will compete. That can include vertical integration, strong retail presence, brand recognition or relationships that secure distribution. Scale is most valuable when it improves margins and strengthens market position. It is less meaningful when it simply increases exposure.
RELATED: The cannabis industry keeps getting one thing wrong
The third factor is management discipline. Every operator claims to have a strong team. What matters is how that team plans for uncertainty.
In cannabis, pricing pressure is not hypothetical. Operators entering a market may see wholesale prices at $1,900 per pound, but long-term assumptions often need to reflect significantly lower levels. Fundable operators do not underwrite to current pricing. They assume prices will fall and build cost structures that can withstand that reality. They focus on production efficiency, cost control, and long-term sustainability.
This discipline also shows up in capital allocation. Earlier in the industry’s growth cycle, it was common to see overbuilt facilities and misallocated capital that did not materially improve performance. Today, capital providers ask whether incremental investment translates into measurable returns, and operators that cannot answer that question clearly will find it harder to access capital.
Strong operators understand that capital efficiency matters as much as revenue growth, and the broader credit environment reinforces these trends. Operators cannot rely on regulatory change to improve their economics in the near term, and they need to perform under current market conditions. That reality is shaping a more disciplined industry. Capital is still flowing, but it is increasingly directed toward operators that demonstrate consistent cash flow, strong market positioning and realistic execution.
In today’s cannabis market, capital is not chasing growth. It is rewarding proof.
*This article was submitted by an unpaid guest contributor. The opinions or statements within do not necessarily reflect those of GreenState or HNP. The author is solely responsible for the content.